Literature DB >> 28031678

A Case of Heparin-Induced Thrombocytopenia Type 2 after Repair of Juxtarenal Abdominal Aortic Aneurysm.

Jun Watanabe1, Kengo Nishimura2, Shigeto Miyasaka1, Keisuke Morimoto1, Takafumi Hamasaki3, Shingo Ishiguro4.   

Abstract

Heparin-induced thrombocytopenia (HIT) is still a relatively uncommon condition and it is not well known how to administer argatroban during continuous hemodiafiltration (CHDF). A 72-year-old man required CHDF with heparin because of the oliguria and hyperpotassemia directly after the open repair of a juxtarenal abdominal aortic aneurysm. As the postoperative blood platelet count dropped and there was a thrombus in the CHDF circuit, HIT was suspected and nafamostat mesilate, but not heparin, was immediately administered for CHDF. As heparin-platelet factor 4 complex was positive, we diagnosed him with HIT and started argatroban while monitoring the activated clotting time (ACT), resulting in no further obstruction of the CHDF and an increase in the platelets. There was no disadvantage for administering nafamostat mesilate which we have commonly used instead of heparin, we should have used argatroban once we suspected HIT. It may be important to consider the history of heparin especially in administering heparin and it may be useful to monitor the ACT when initially starting argatroban for patients with HIT.

Entities:  

Keywords:  argatroban; heparin-induced thrombocytopenia; nafamostat mesilate

Year:  2015        PMID: 28031678      PMCID: PMC5186222          DOI: 10.1055/s-0035-1558464

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  8 in total

1.  Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia.

Authors:  B Pötzsch; W P Klövekorn; K Madlener
Journal:  N Engl J Med       Date:  2000-08-17       Impact factor: 91.245

2.  Temporal aspects of heparin-induced thrombocytopenia.

Authors:  T E Warkentin; J G Kelton
Journal:  N Engl J Med       Date:  2001-04-26       Impact factor: 91.245

Review 3.  Heparin-induced thrombocytopenia: a review.

Authors:  Bruno Girolami; Antonio Girolami
Journal:  Semin Thromb Hemost       Date:  2006-11       Impact factor: 4.180

Review 4.  Heparin-induced thrombocytopenia: a historical perspective.

Authors:  John G Kelton; Theodore E Warkentin
Journal:  Blood       Date:  2008-10-01       Impact factor: 22.113

5.  Endovascular repair of an extracranial internal carotid artery aneurysm complicated by heparin-induced thrombocytopenia and thrombosis.

Authors:  M R van Sambeek; C M Segeren; L C van Dijk; J A van Essen; D W Dippel; H van Urk
Journal:  J Endovasc Ther       Date:  2000-10       Impact factor: 3.487

Review 6.  Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Theodore E Warkentin; Andreas Greinacher
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

7.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

Authors:  T E Warkentin; M N Levine; J Hirsh; P Horsewood; R S Roberts; M Gent; J G Kelton
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

8.  Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Theodore E Warkentin; Andreas Greinacher; Andreas Koster; A Michael Lincoff
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.